It is worth noting that high expression levels of immune checkpoints, including PD-1, its ligand, and CTLA-4, were observed in neoplastic mast cells, despite limited knowledge on the immunological behavior of mast cell tumors (MCTs). This evidence concerns the gene CTLA4 and mast cell neoplasm.